Cite Filings / OTLK / 0001104659-22-129703
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
424B5

Prospectus

Outlook Therapeutics, Inc. · Filed 2022-12-23 · Acc 0001104659-22-129703

Documents 1

  • 424B5 Prospectus , tm2233312-1_424b5.htm

Around this filing

  • 2023-05-16 424B5 Prospectus
  • 2022-12-29 10-K Annual Report
  • 2022-12-29 4 Director acquired 14,230,418 shares (grant or award)
  • 2022-12-23 8-K Material agreement · Unregistered share sale · Other events
  • 2022-12-23 424B5 Prospectus
  • 2022-12-22 8-K Material agreement · New debt or obligation · Unregistered share sale · Other events
  • 2022-06-17 424B5 Prospectus

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm2233312-1_424b5.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…